Results for tag: "Exisulind"

Exisulind is an oncology drug used to treat certain types of cancer. It is a prodrug of sulindac, a nonsteroidal anti-inflammatory drug (NSAID). Exisulind works by inhibiting the enzyme cyclooxygenase-2 (COX-2), which is involved in the production of prostaglandins, which are involved in inflammation and cancer. Exisulind has been approved by the US Food and Drug Administration (FDA) for the treatment of colorectal cancer and is being studied for its potential use in other types of cancer. Exisulind is a promising drug for the treatment of cancer, as it has been shown to reduce the risk of recurrence and progression of colorectal cancer. It is also being studied for its potential use in other types of cancer, such as breast, lung, and prostate cancer. Some companies in the Exisulind market include Merck, Pfizer, and AstraZeneca. Show Less Read more